Andrew Mears
Amministratore Delegato presso DELTEX MEDICAL GROUP PLC
Patrimonio netto: 18 537 $ in data 31/05/2024
Posizioni attive di Andrew Mears
Società | Posizione | Inizio | Fine |
---|---|---|---|
DELTEX MEDICAL GROUP PLC | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 13/06/2018 | - | |
Corporate Officer/Principal | 01/01/2016 | 13/06/2018 | |
Vendite & Marketing | 01/01/1989 | 01/01/2016 | |
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Direttore/Membro del Consiglio | 01/11/2004 | - |
Amministratore Delegato | - | - | |
All-Party Parliamentary Groups | Corporate Officer/Principal | - | - |
Storia della carriera di Andrew Mears
Statistiche
Distribuzione geografica
Regno Unito | 3 |
2 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Deltex Medical Group Plc | |
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
All-Party Parliamentary Groups |
- Borsa valori
- Insiders
- Andrew Mears
- Esperienza